New insights into the crosstalk between Shigella and T lymphocytes

Trends in Microbiology

Volumn 22, Issue 4, 2014, Pages 192-198

  Salgado Pabón, Wilmara ^a,c   Konradt, Christoph ^a,d   Sansonetti, Philippe J ^a,b   Phalipon, Armelle ^a  

^a INSTITUT PASTEUR   (France)

^b Chaire de Microbiologie et Maladies Infectieuses Collège de France ^*  (France)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adaptive immunity; Lymph node; Shigella; T lymphocyte; Two photon microscopy; Type III secretion system

Indexed keywords

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; EFFECTOR CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LYMPHOCYTE MIGRATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SHIGELLA FLEXNERI; SHIGELLOSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

BACTERIA (MICROORGANISMS); SHIGELLA; SHIGELLA FLEXNERI;

ADAPTIVE IMMUNITY; LYMPH NODE; SHIGELLA; T LYMPHOCYTE; TWO-PHOTON MICROSCOPY; TYPE III SECRETION SYSTEM;

CELL MOVEMENT; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MODELS, BIOLOGICAL; SHIGELLA FLEXNERI; T-LYMPHOCYTES;

EID: 84897394561     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2014.02.002     Document Type: Review

References (59)

1. McCullough K.C., et al. Dendritic cells-at the front-line of pathogen attack. Vet. Immunol. Immunopathol. 2009, 128:7-15.
2. Bousso P. T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat. Rev. Immunol. 2008, 8:675-684.
3. Junt T., et al. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat. Rev. Immunol. 2008, 8:764-775.
4. Nicholson D., Nicholson L.B. A simple immune system simulation reveals optimal movement and cell density parameters for successful target clearance. Immunology 2008, 123:519-527.
5. Carayol N., Tran Van Nhieu G. Tips and tricks about Shigella invasion of epithelial cells. Curr. Opin. Microbiol. 2013, 16:32-37.
6. Dunn J.D., Valdivia R.H. Uncivil engineers: Chlamydia, Salmonella and Shigella alter cytoskeleton architecture to invade epithelial cells. Future Microbiol. 2010, 5:1219-1232.
7. Camacho A.I., et al. Recent progress towards development of a Shigella vaccine. Expert Rev. Vaccines 2013, 12:43-55.
8. Kaminski R.W., Oaks E.V. Inactivated and subunit vaccines to prevent shigellosis. Expert Rev. Vaccines 2009, 8:1693-1704.
9. Phalipon A., et al. Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?. Microbes Infect. 2008, 10:1057-1062.
10. Kweon M.N. Shigellosis: the current status of vaccine development. Curr. Opin. Infect. Dis. 2008, 21:313-318.
11. Mathan M.M., Mathan V.I. Morphology of rectal mucosa of patients with shigellosis. Rev. Infect. Dis. 1991, 13:S314-S318.
12. Perdomo O.J., et al. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J. Exp. Med. 1994, 180:1307-1319.
13. Ashida H., et al. Shigella infection of intestinal epithelium and circumvention of the host innate defense system. Curr. Top. Microbiol. Immunol. 2009, 337:231-255.
14. Parsot C., Sansonetti P.J. Invasion and the pathogenesis of Shigella infections. Curr. Top. Microbiol. Immunol. 1996, 209:25-42.
15. Phalipon A., Sansonetti P.J. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?. Immunol. Cell Biol. 2007, 85:119-129.
16. Parsot C. Shigella type III secretion effectors: how, where, when, for what purposes?. Curr. Opin. Microbiol. 2009, 12:110-116.
17. Schroeder G.N., Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 2008, 21:134-156.
18. Ogawa M., et al. The versatility of Shigella effectors. Nat. Rev. Microbiol. 2008, 6:11-16.
19. Ingersoll M.A., Zychlinsky A. ShiA abrogates the innate T-cell response to Shigella flexneri infection. Infect. Immun. 2006, 74:2317-2327.
20. Le Bourhis L., et al. MAIT cells, surveyors of a new class of antigen: development and functions. Curr. Opin. Immunol. 2013, 25:174-180.
21. Raqib R., et al. Innate immune responses in children and adults with shigellosis. Infect. Immun. 2000, 68:3620-3629.
22. Raqib R., et al. Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2. Infect. Immun. 2002, 70:3199-3207.
23. Weiss G.E., et al. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog. 2010, 6:e1000912.
24. Sellge G., et al. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. J. Immunol. 2010, 184:2076-2085.
25. Jehl S.P., et al. Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri. Infect. Immun. 2011, 79:2021-2030.
26. Sperandio B., et al. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J. Exp. Med. 2008, 205:1121-1132.
27. Konradt C., et al. The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism. Cell Host Microbe 2011, 9:263-272.
28. Weber S.S., et al. Pathogen trafficking pathways and host phosphoinositide metabolism. Mol. Microbiol. 2009, 71:1341-1352.
29. Smith K., et al. Enteropathogenic Escherichia coli recruits the cellular inositol phosphatase SHIP2 to regulate actin-pedestal formation. Cell Host Microbe 2010, 7:13-24.
30. Bakowski M.A., et al. The phosphoinositide phosphatase SopB manipulates membrane surface charge and trafficking of the Salmonella-containing vacuole. Cell Host Microbe 2010, 7:453-462.
31. Rayne F., et al. Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J. 2010, 29:1348-1362.
32. Hao J.J., et al. Phospholipase C-mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane. J. Cell Biol. 2009, 184:451-462.
33. Coombes J.L., Robey E.A. Dynamic imaging of host-pathogen interactions in vivo. Nat. Rev. Immunol. 2010, 10:353-364.
34. Salgado-Pabon W., et al. Shigella impairs T lymphocyte dynamics in vivo. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:4458-4463.
35. Celli S., et al. Decoding the dynamics of T cell-dendritic cell interactions in vivo. Immunol. Rev. 2008, 221:182-187.
36. Millington O.R., et al. Malaria impairs T cell clustering and immune priming despite normal signal 1 from dendritic cells. PLoS Pathog. 2007, 3:1380-1387.
37. Bajenoff M., et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 2006, 203:619-631.
38. Chtanova T., et al. Dynamics of neutrophil migration in lymph nodes during infection. Immunity 2008, 29:487-496.
39. John B., et al. Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog. 2009, 5:e1000505.
40. Hickman H.D., et al. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 2008, 9:155-165.
41. Aoshi T., et al. Bacterial entry to the splenic white pulp initiates antigen presentation to CD8+ T cells. Immunity 2008, 29:476-486.
42. Egen J.G., et al. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 2008, 28:271-284.
43. Obeid M., et al. Skin-draining lymph node priming is sufficient to induce sterile immunity against pre-erythrocytic malaria. EMBO Mol. Med. 2013, 5:250-263.
44. Khanna K.M., et al. In situ imaging of the endogenous CD8 T cell response to infection. Science 2007, 318:116-120.
45. Puhar A., et al. A Shigella effector dampens inflammation by regulating epithelial release of danger signal ATP through production of the lipid mediator PtdIns5P. Immunity 2013, 39:1121-1131.
46. Durand E.A., et al. The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection. Cell. Microbiol. 2010, 12:1064-1082.
47. Koberle M., et al. Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model. PLoS Pathog. 2009, 5:e1000551.
48. McLaughlin L.M., et al. The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration. PLoS Pathog. 2009, 5:e1000671.
49. Paccani S.R., et al. The Bordetella pertussis adenylate cyclase toxin binds to T cells via LFA-1 and induces its disengagement from the immune synapse. J. Exp. Med. 2011, 208:1317-1330.
50. Richmond J.M., et al. Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis preferentially inhibits sphingosine-1-phosphate-induced migration of Th1 cells. J. Immunol. 2012, 189:5886-5895.
51. Park I.W., He J.J. HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants. J. Leukoc. Biol. 2009, 86:1171-1178.
52. Stolp B., et al. HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. Cell Host Microbe 2009, 6:174-186.
53. Gerke C., et al. The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. J. Exp. Med. 2005, 201:361-371.
54. Trulzsch K., et al. Yersinia outer protein P inhibits CD8 T cell priming in the mouse infection model. J. Immunol. 2005, 174:4244-4251.
55. Gebert B., et al. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003, 301:1099-1102.
56. Sewald X., et al. Sticky socks: Helicobacter pylori VacA takes shape. Trends Microbiol. 2008, 16:89-92.
57. Santhanam S.K., et al. The virulence polysaccharide Vi released by Salmonella typhi targets membrane prohibitin to inhibit T cell activation. J. Infect. Dis. 2014, 10.1093/infdis/jiu064.
58. Marketon M.M., et al. Plague bacteria target immune cells during infection. Science 2005, 309:1739-1741.
59. Richter-Dahlfors A., et al. Tissue microbiology provides a coherent picture of infection. Curr. Opin. Microbiol. 2012, 15:15-22.